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By Akira KOBATA*1,†
(Communicated by Tamio YAMAKAWA, M.J.A.)
Abstract: Comparative study of the oligosaccharide proﬁles of individual human milk
revealed the presence of three diﬀerent patterns. Four oligosaccharides containing the Fuc,1-2Gal
group were missing in the milk of non-secretor, and three oligosaccharides containing the Fuc,1-
4GlcNAc group were missing in the milk of Lewis negative individuals. Disappearance of some
major oligosaccharides in these samples led to the ﬁnding of ﬁve novel minor oligosaccharides, which
were hidden under the missing oligosaccharides. Following these studies, structures of many novel
milk oligosaccharides were elucidated. At least 13 core oligosaccharides were found in these
oligosaccharides. By adding ,-fucosyl residues and sialic acid residues to these core oligosaccharides,
more than one hundred oligosaccharides were formed. All these oligosaccharides contain lactose at
their reducing termini. This evidence, together with the deletion phenomena found in the milk
oligosaccharides of non-secretor and Lewis negative individuals, suggested that the oligosaccharides
are formed from lactose by the concerted action of glycosyltransferases, which are responsible for
elongation and branching of the Gal-1-4GlcNAc group in the sugar chains of glycoconjugates on the
surface of epithelial cells. Therefore, oligosaccharides in human milk could include many structures,
starting from the Gal-1-4GlcNAc group in the sugar chains of various glycoconjugates. Many lines
of evidence recently indicated that virulent enteric bacteria and viruses start their infection by
binding to particular sugar chains of glycoconjugates on the target cell surfaces. Therefore, milk
oligosaccharides could be useful for developing drugs, which inhibit the infection of bacteria and
viruses.
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Introduction
Milk contains various oligosaccharides in addi-
tion to glycoproteins, glycopeptides and glycolipids,
many of which are found speciﬁcally in this particular
secretion. These components occur in large amounts
in the milk secreted at early stages of lactation.
Among them, casein and lactose are important
nutritional ingredients, while IgA works as a compo-
nent of transfer immunity for babies.1) Lactoferrin
plays a role to suppress the growth of bacteria by
binding to the iron in milk.2),3)
However, the physiological roles of other minor
components, such as oligosaccharides in milk, are
mostly unknown. Among the milk of mammals,
human milk is unique because it contains a large
number of oligosaccharides.
In 1933, Polonovski and Lespagnol found a new
oligosaccharide containing nitrogen in human milk,
and named it “gynolactose”.4) Over two decades later,
Polonovski and Montreuil found that gynolactose is
actually a mixture of more than ten oligosaccharides,
and nitrogen is included only in part of them.5)
Independent to their study, Kuhn’s group in the
Max Planck Institute in Heidelburg reached to the
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3GlcNAc-1-; Type II chain: Gal-1-4GlcNAc-1-.
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of Biﬁdus factor.
It has been known since 1900 that the feces of
breast-fed babies are more acidic than those of
artiﬁcially nourished babies.6),7) These papers drew
widely scientist’s notice, when Grulee et al. reported
that breast-feeding was strongly associated with a
lower incidence of diarrhea, otitis media, and
respiratory diseases8) in suckling babies. Paul
György, who was the Professor of Pediatrics in
Pennsylvania University, considered that this is
because Lactobacillus biﬁdus becomes a predominant
intestinal ﬂora of babies fed with human milk. This
bacterium digests lactose, and produces large
amounts of lactic acid and acetic acid. The acidic
condition in the intestine of babies suppresses the
growth of many other microorganisms, and may
protect babies from harmful intestinal infection.
Schönfeld9) reported that the whey fraction of
human milk contains a growth-promoting factor for
Lactobacillus biﬁdus var. pennsylvanics, and named
it Biﬁdus factor. In collaboration with György,
Kuhn started a series of systematic investigations to
elucidate the chemical entity of Biﬁdus factor,10)–12)
and found many oligosaccharides in human milk.
Until 1965, structures of fourteen oligosaccha-
rides shown in Table 1 were determined by Kuhn’s
group and Montreuil’s group.13)–25)
All of these oligosaccharides contain lactose at
their reducing termini. An interesting ﬁnding was
Table 1. Structures of human milk oligosaccharides found until 1965
A. KOBATA [Vol. 86, 732that some of these oligosaccharides showed haptenic
activities of blood group determinants:21),26) 2′-FL
and LNF-I showed haptenic activity of H determi-
nant, LND-I showed activity of Leb determinant,
and LNF-II showed activity of Lea determinant.
These ﬁndings of human milk oligosaccharides
signiﬁcantly contributed to the elucidation of the
structures of H and Lewis blood group determi-
nants.27)
Elucidation of the biochemical basis of non-
secretor phenomenon and Lewis-negative
phenomenon based on the ﬁnding of correlation
of the occurrence of fucose-containing
oligosaccharides with blood types of the donors
In 1967, Grollman and Ginsburg28) found an
interesting fact that 2′-FL was not detected in the
milk samples obtained from individuals of non-
secretor blood type. Non-secretor individuals express
ABO blood types on the surface of their erythrocytes
according to their genetic background of ABO locus,
but not in the glycoproteins secreted from the
epithelial cells of mucous glands. In order to extend
this interesting ﬁnding further, Kobata et al.29)
devised a new technique to ﬁngerprint the oligosac-
charides by using small amount of milk samples. As
shown in Fig. 1A, the fourteen milk oligosaccharides
in Table 1 were successfully fractionated by using
approximately 10ml of milk samples.
By analyzing around 50 human milk samples,
three types of oligosaccharide proﬁles were found to
occur in human milk. Approximately 80% of human
milk contained all fourteen oligosaccharides as shown
in Fig. 1A. Approximately 15% of human milk lacked
four oligosaccharides as shown in Fig. 1B, and
remaining 5% lacked three oligosaccharides as shown
in Fig. 1C. The missing oligosaccharides were in-
dicated in Fig. 1B and C by dotted lines. The small
grey spots, detected at the positions of missing
oligosaccharides, are minor oligosaccharides hidden
under the major oligosaccharides.
Important evidence was that all mothers whose
milk gave the proﬁle Fig. 1B were non-secretors, and
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Fig. 1. Three typical ﬁngerprinting patterns obtained from the
oligosaccharide fraction of milk sample, collected from a single
donor. The fraction numbers as indicated by “TUBE NUMBER”
in abscissa were obtained by Sephadex G-25 column chromatog-
raphy of human milk oligosaccharide fraction. Aliquot of the
fractions were spotted at the origin of a sheet of a ﬁlter paper,
and subjected to chromatography using ethylacetate/pyridine/
acetic acid/water (5:5:1:3) as solvent. Black spots represent
oligosaccharides visualized by alkaline-AgNO3 reagent, and
hatched ones encircled by black line represent those detected
by both alkaline-AgNO3 reagent and thiobarbituric acid reagent.
Spots shown by dotted lines were missing in the pattern. Grey
spots detected at the positions of missing oligosaccharides are
minor oligosaccharides hidden under the major oligosaccharides.
A, the pattern obtained from milk samples of Lea+b+ individuals;
B, the pattern obtained from milk samples of Lea+b− (non-
secretor) individuals; C, the pattern obtained from milk samples
of Lea−b− individuals. Revised from the ﬁgure in Glycoconj. J.
17, 443–464 (2000) with kind permission from Springer
Science+Business media.
Oligosaccharides in human milk No. 7] 733those who gave the proﬁle Fig. 1C were all Lewis
negative, lacking both Lea and Leb antigens.
The four oligosaccharides: 2′-FL, LD, LNF-I,
and LND-I, which were missing in the milk of non-
secretor individuals, contain the Fuc,1-2Gal group
in common. Namely, the secretory organs of non-
secretor individuals probably lack the fucosyltrans-
ferase responsible for formation of the disaccharide
group. The three oligosaccharides: LNF-II, LND-I,
and LND-II, which were missing in Lewis negative
individuals, all contain the Fuc,1-4GlcNAc group,
indicating that these mothers may lack another
fucosyltransferase responsible for formation of the
Fuc,1-4GlcNAc group.
These estimations were proven by enzymatic
studies.30),31)
Finding of minor oligosaccharides, which contain
blood group A determinant, in human milk
In Table 2, the structures of H antigenic
determinant, which is the major antigen of human
O-blood type, and blood type A and B antigenic
determinants are summarized. As easily speculated
from the structures of the three antigenic determi-
nants, blood types A and B antigenic determinants
are formed by adding GalNAc residue and Gal
residue to H antigenic determinant, respectively.
Although oligosaccharides containing blood type A
and B antigenic determinants were not included
among the milk oligosaccharides listed in Table 1, an
,-N-acetylgalacosaminyltransferase (A-enzyme) and
an ,-galactosyltransferase (B-enzyme) were found to
occur in the milk of blood type A and B individuals,
respectively.32),33) These enzymes catalyze the addi-
tion of an ,-GalNAc residue and an ,-Gal residue to
the C-3 position of the Gal residue of the Fuc,1-2Gal
group, respectively. GalNAc,1-3(Fuc,1-2)Gal-1-
4Glc and GalNAc,1-3(Fuc,1-2)Gal-1-3GlcNAc-1-
3Gal-1-4Glc, which were formed respectively from 2′-
FL and LNF-I by the catalysis of partially puriﬁed A-
enzyme, showed haptenic activity of blood type A.34)
Occurrence of these haptenic tetrasaccharide (PI)
and hexasaccharide (PII) in the milk samples of
blood type A secretor individuals was conﬁrmed as
summarized in Table 3. The amounts of both
haptenic oligosaccharides in blood type A milk
samples varied by individuals from 0.2 to 13nmol
per ml of milk. These values are from one-hundredth
to one-thousandth of those for LNT, LNF-I and
LNF-II.
Structures of the minor oligosaccharides detected
in the milk samples obtained from non-secretor
individuals and Lewis negative individuals
As named by white letters in Fig. 1B and C, ﬁve
novel oligosaccharides in total were found in the
milk samples of non-secretor and Lewis negative
individuals. Structures of these oligosaccharides were
elucidated as summarized in Table 4.35)–39)
Among them, LNF-III served as an important
haptenic oligosaccharide to investigate the functional
role of Lex antigen.40) LNH and LNnH served as
useful models of branched core structures in the later
studies of many blood group related antigens.41),42)
Before the structures of these oligosaccharides
were elucidated, lactose, LNT and LNnT were
considered as the cores of human milk oligosaccha-
rides. Branched hexasaccharides: LNH and LNnH
were newly added as cores, and a large number of
fucosyl and sialyl derivatives of these newly added
cores were found in human milk as shown in
Tables 5–7.38),43)–55)
Table 2. Structures of ABO blood group antigenic determinants
*Those containing Gal-1-3GlcNAc-1- and Gal-1-4GlcNAc-1-
are discriminated by the name of H-1 and H-2, respectively.
Table 3. Contents of PI and PII in human milk
Donors Blood type Secretor status
Oligosaccharides
PI PII
nmol/ml milk
B.J. A2 secretor 13 4
E.K. A2 secretor 3 2
E.W. A1 secretor 0.4 0.2
M.C. A1 secretor 8 4
M.R. A1 secretor 0.2 0.3
K.C. A1 secretor 6 1
B.B. A1 non-secretor <0.1 <0.1
H.S. O secretor <0.1 <0.1
M.S. B secretor <0.1 <0.1
A. KOBATA [Vol. 86, 734Table 5. Human milk oligosaccharides with lactose, LNT and LNnT as cores
Table 4. Novel oligosaccharides isolated from milk of non-secretor and Lewis
negative individuals
Oligosaccharides in human milk No. 7] 735For the structural studies of these novel milk
oligosaccharides, many new sensitive analytical
techniques, such as tritium-labeling,56) sequential
exoglycosidase digestion,57),58) and sensitive methyl-
ation analysis suitable for the amino sugar-contain-
ing oligosaccharides59) were established. These new
techniques play important roles in the later struc-
tural study of the sugar chains of various glycocon-
jugates. In addition to the physicochemical analyses
such as NMR and mass-spectrometry, recycling
chromatography devised by Donald et al.43) was
found to be eﬀective for the study of milk oligosac-
charides.
Looking at the structures of these oligosaccha-
rides silhouettes several interesting structural rules.
As shown in Table 6, the Fuc,1-2Gal group is not
evenly distributed to the two Gal-1-GlcNAc groups
of the branched arms of LNH, but is rather limited to
the arm extending from C-3 position of the branching
Gal.42) Finding of the Fuc,1-3Gal group in a
fucosylated LNH is also noteworthy.49) This group
is limited to the Type II chain in contrast to the
Fuc,1-2Gal group. Many fucosyltransferases have
been cloned in recent years.60) However, no enzyme to
catalyze the formation of the Fuc,1-3Gal group has
been reported.
Several oligosaccharides containing both Fuc,1-
2Gal group and sialic acid were detected. It was
conﬁrmed that these oligosaccharides could not work
as the substrate of A-enzyme (Kobata et al.,
unpublished data). Therefore, sialylation of the sugar
chains may inhibit the conversion of H-antigen to A-
antigen.
Many novel cores were found
in the human milk oligosaccharides
As described already, structural study of human
milk oligosaccharides get started by the interest of
their relation to blood group antigens. The develop-
ment of research as introduced so far and the
possibility of important functions of these oligosac-
charides aroused the interest of many researchers,
and the structures of remaining larger oligosaccha-
rides were investigated. As shown in Table 8, we
found four novel core oligosaccharides: para-Lacto-N-
hexaose,61) para-Lacto-N-neohexaose,61) Lacto-N-oc-
taose,62) and Lacto-N-neooctaose62) in human milk.
Other groups found three additional novel core
Table 6. Human milk oligosaccharides with LNH as a core. Numbers in the parentheses indicate those of references
A. KOBATA [Vol. 86, 736oligosaccharides: iso-Lacto-N-octaose,63) para-Lacto-
N-octaose,55) and Lacto-N-decaose.64) Quite recently,
Amano et al.65) reported the occurrence of an
isomeric decasaccharide as another core in milk
oligosaccharides. Therefore, at least 13 core oligosac-
charides have been found for human milk oligosac-
charides until now.
All of these core oligosaccharides contain lactose
at their reducing termini. Based on this evidence, all
human milk oligosaccharides are considered to be
produced by the action of glycosyltransferases of
epithelial cells, which are responsible for formation of
the sugar chains of glycoproteins and glycolipids in
the cells. Namely, by the action of iGnT66) on lactose,
which is synthesized in a large amount by the action
of -4GalT-I and ,-lactalbumin, GlcNAc-1-3Gal-1-
4Glc is formed as shown in Fig. 2. All linear core
oligosaccharides might be formed by the concerted
actions of -4GalT67) and iGnT as shown in the left
hand side of Fig. 3. The sugar chains, produced by
the concerted action of the two glycosyltransferases,
are all neo-type, which has only the repeating
structures of the Gal-1-4GlcNAc-1-3 group. How-
ever, when the Gal-1-3GlcNAc-1-3 group is formed
by the action of -3GalT68) instead of -4GalT,
extension of the sugar chain might stop there.
Core milk oligosaccharides with branched struc-
tures might be produced by the action of IGnT69) as
shown in Fig. 2, and in the right hand side of Fig. 3.
The thirteen core oligosaccharides, thus formed,
are further elongated to the fucosylated and/or
sialylated oligosaccharides by the actions of fucosyl-
transferases and/or sialyltransferases. In Tables 5–7,
and Tables 9 and 10, all sialylated and fucosylated
oligosaccharides, reported so far, are summarized.
Many fucosyl derivatives of Lacto-N-decaose and its
Table 7. Human milk oligosaccharides with LNnH as a core
Oligosaccharides in human milk No. 7] 737isomer were reported by Chai et al.,76) and Amano
et al.65) Although only one tetra-fucosyl derivative
was reported for para-Lacto-N-octaose,55) many
fucosyl and/or sialyl derivatives will be found for
this core oligosaccharide in the future.
Important evidence is that Lacto-N-octaose and
Lacto-N-neooctaose were not detected by mass-
spectrometric analysis.55) This evidence should be
explained in the future for the sound development of
mass-spectrometric methods.
Various problems related to the activity
of Biﬁdus factor in milk
The problem of the chemical entity of Biﬁdus
factor had been considered to be solved, when
Lactobaccilus biﬁdus var. pennsylvanicus was found
to request GlcNAc as a growth factor and only the
milk oligosaccharides containing GlcNAc residue as
Biﬁdus factor. However, the project is developing
now to a new aspect by the ﬁnding that human milk
oligosaccharides show a growth activity working
speciﬁcally for various Biﬁdus strains as described
below.
It was found that most of human milk oligosac-
charides are not degraded by the action of exoglyco-
sidases in digestive tract and reach to intestine.
Table 8. Various core structures found in human milk oligosaccharides
Fig. 2. Elongation of lactose and N-acetyllactosamine group of
the sugar chain of glycoconjugates by the action of iGnT and
IGnT. R represents the aglycon moieties of glycoconjugates.
Revised from the ﬁgure in Chang Gung Medical J. 26, 620–636
(2003).
A. KOBATA [Vol. 86, 738Because of this characteristics, these oligosaccha-
rides are now classiﬁed as water-soluble ﬁbers.77)–81)
Accordingly, these oligosaccharides must ﬁrst be
digested to their monosaccharide constituents in
order to be used by intestinal ﬂora as nutrients.
However, it is not so easy for bacteria in intestine
to digest human milk oligosaccharides, because
most of the --galactosidases of intestinal bacteria
hydrolyze the Gal-1-4GlcNAc group but not the
Gal-1-3GlcNAc group, which amply occurs at the
non-reducing termini of human milk oligosaccha-
rides.58)
The research group of Kenji Yamamoto found
that a lacto-N-biosidase, reported by Sano et al.82) in
the culture ﬂuid of Streptomyces sp. 142, was widely
found in Lactobaccilus biﬁdus strains, but not in
other intestinal bacteria.83) This endoglycosidase
eﬀectively releases the Gal-1-3GlcNAc group from
non-reducing termini of various oligosaccharides.
They also found a transporter in the membrane of
L. biﬁdus strains. This transporter speciﬁcally trans-
ports Gal-1-3GlcNAc from culture medium into
cells.84)
Meanwhile, Kitaoka et al.85) found in the culture
ﬂuid of Biﬁdobacterium biﬁdum JCM1254 an en-
zyme, which converts the Gal-1-3GlcNAc to Gal,1-
PO4 and GlcNAc, and named it lacto-N-biose
phosphorylase. An interesting evidence is that this
enzyme also works on the Gal-1-3GalNAc, which is
released from O-linked sugar chains by the action of
endo-,-N-acetylgalactosaminidase,86) and convert it
to Gal,1-PO4 and GalNAc, but not on the Gal-1-
4GlcNAc group. They successfully cloned the gene of
this enzyme from Biﬁdobacterium longum JCM1217,
and further found a series of genes of enzymes, which
are responsible for the metabolism of monosaccha-
rides constructing human milk oligosaccharides, in
the operon containing the gene of lacto-N-biose
phosphorylase. Based on this ﬁnding, they proposed
the metabolic pathway of human milk oligosaccha-
rides by the bacterium.
These results indicated that L. biﬁdus strains are
equipped with a series of special catabolic mecha-
nism, which speciﬁcally uses the oligosaccharides
having the Gal-1-3GlcNAc group in their termini for
metabolic sources. Therefore, human milk oligosac-
charides, which are enriched in the Gal-1-3GlcNAc
group in their non-reducing termini, speciﬁcally work
as nutritional sources for L. biﬁdus strains.
A trial to apply human milk oligosaccharides as
drugs to prevent bacterial and viral infection
As already described, human milk oligosaccha-
rides are synthesized by the concerted action of a
series of glycosyltransferases, which are responsible
for formation of the sugar chains of glycoproteins
and glycolipids produced by the epithelial cells of
mammary gland. Accordingly, human milk oligosac-
charides may be useful for elucidating the structures
of potential ligands for cell adhesion molecules.87)
Actually, LNF-III was eﬀectively used to elucidate
the physiological role of Lex antigen.40)
Fig. 3. Biosynthetic pathways leading to various core oligosaccharides from GlcNAc-1-3Gal-1-4Glc and GlcNAc-1-6(GlcNAc-1-
3)Gal-1-4Glc.
Oligosaccharides in human milk No. 7] 739It was known that the infection of many bacteria
and viruses starts by binding to particular sugar
chains of glycoconjugates on the surface of cells,
which are constructing the mucous epithelium of
digestive tracts and respiratory tracts. Therefore,
human milk oligosaccharides might be useful for
elucidating the structure of target sugar chain of each
bacterium or virus on the surface of epithelial cells.
After entering into 1990th, several research
groups started to report the phenomenon that some
of the human milk oligosaccharides inhibit attach-
ment of intestinal bacteria to the surface of the
epithelial cells of intestine.88)–90) Based on these
ﬁndings, Newburg started to investigate the possi-
bility that human milk oligosaccharides may be
useful for developing new drugs to protect suckling
babies from bacterial and viral infections.91)
Newburg reviewed that addition of various
oligosaccharides and glycoconjugates to milk pre-
vents babies from infectious diseases.92)
One of the toxins produced by enterotoxigenic
E. coli is called stable toxin (STa), because of its
stability to organic solvent and heat. STa induces
secretory diarrhea by activating guanylate cyclase
of the surface of intestinal epithelial cells.93) It
was known that T84 cells, established by
Dharmsathaphorn, diﬀerentiate in culture and ex-
press various features of intestinal epithelium includ-
ing formation of microvillae and transmembrane
guanylate cyclase.94)–96)
Table 9. Human milk oligosaccharides containing para-Lacto-N-hexaose (para-
LNH) and para-Lacto-N-neohexaose (para-LNnH) as cores
A. KOBATA [Vol. 86, 740By using this cultured cells, Crane et al. found
that a crude mixture of human milk oligosaccharides
showed a dose-dependent inhibition for the STa-
induced cGMP production.97) The inhibition activity
was expressed by the fucosylated oligosaccharide
fraction, but not by the non-fucosylated oligosaccha-
Table 10. Human milk oligosaccharides containing Lacto-N-octaose, Lacto-N-neooctaose, and iso-
Lacto-N-octaose as coses. The numbers in the parentheses indicate the numbers of references
Oligosaccharides in human milk No. 7] 741ride fraction, which were obtained by passing
through an immobilized Ulex europaeus column.
More recently, Morrow et al. reported that only the
milk oligosaccharides, containing the Fuc,1-2Gal
group at their non-reducing termini, showed the
inhibitory activity.98)
Ruiz-Palacios et al. found that adhesion of
Campyrobacter jejuni to the surface of intestinal
epithelia is inhibited by the human milk oligosac-
charides, which contain the Fuc,1-2Gal-1-4GlcNAc
group (H-2 antigen) at their non-reducing termini.99)
They further conﬁrmed that adhesion of Campyr-
obacter jejuni to H-2 antigen expressed on the
surface of the epithelial cells of human small
intestine is essential for its infection, by indicating
that the bacterium cannot bind to the surface of
CHO cells, but binds well to the surface of CHO
cells transfected with human ,1,2-fucosyltransferase
gene.
According to Le Pandu,100) non-secretor individ-
uals are resistant to Norwalk virus (NV) infection.
This evidence indicated that H-1 antigenic determi-
nant expressed on the surface of the epithelial cells of
human intestine is working as the receptor to trigger
NV infection. Actually, it was found that NV
infection was inhibited by milk obtained from
secretor mothers, which are known to contain a large
amount of oligosaccharides containing the H-1
antigenic determinant, but not by milk from non-
secretor mothers.
In 2005, Perret et al.101) found that PA-IIL, a
lectin puriﬁed from Pseudomonas aeruginosa, binds
speciﬁcally to 3-FL and human milk oligosaccharides
containing Lea antigenic determinant, and estimated
that Lea and Lex antigenic determinants on the
surface of mucous epithelial cells are the target to
start the infection of P. aeruginosa.
F18-ﬁmbriated E. coli infection to weaned piglet
induces diarrhea and dropsy. Its infection starts by
binding FedF, which is included in F18-ﬁmbria, to
the wall of small intestine of piglet. Quite recently,
Coddens et al.102) found that the adhesion of this
bacteria to the microvilli of piglet small intestine is
inhibited by LNF-I, but not by LNT. Based on this
ﬁnding, they investigated the structures of glyco-
lipids in the mucosa of piglet small intestine, which
bind to FedF, and showed that glycolipids containing
either H-1 antigenic determinant or blood type A
or B antigenic determinant of Type I chain bind
strongly to FedF. Because H-2 and blood type A or B
determinants of Type II chain cannot bind to FedF,
they concluded that H-1 is the basic structure of
FedF ligand, and further addition of Gal or GalNAc
at the C-3 position of the Gal residue of the ligand
enhances the binding to FedF.
Future prospects
As shown by the data, so far introduced, studies
of human milk oligosaccharides are expected to be
very useful for the development of drugs, which are
eﬀective for protection of babies from harmful
infections.
The key to lead to the success of this line of
studies is how one will be able to develop an eﬀective
method to pick up minor but useful oligosaccharides
from the mixture of a large number of diﬀerent milk
oligosaccharides.
Kitagawa et al. reported the structures of a
series of human milk oligosaccharides, which were
retained by an immobilized column of anti-CA19-9
antibody.103) As shown by A–D in Fig. 4, they are
oligosaccharides of various sizes containing the sialyl-
Lea determinant in common. Among them, two
oligosaccharides, C and D, which occur as very minor
components in the oligosaccharide fraction retained
A
B
C
D
E
Fig. 4. Structures of milk oligosaccharides containing the sialyl-
Lea group (A–D), and three human milk oligosaccharides (C–E),
which do not contain the known core oligosaccharides. Taken
from the ﬁgure in Chang Gung Medical J. 26, 620–636 (2003).
A. KOBATA [Vol. 86, 742by the column, have unusual features. They do not
contain lactose, but contain either GlcNAc or Gal
residue at their reducing termini.
Another unusual oligosaccharide (E in Fig. 4),
which does not contain the core structures of milk
oligosaccharides so far introduced, was isolated
from human milk. However, this oligosaccharide
also contains lactose at its reducing terminus.
Therefore, the mechanism to produce oligosaccha-
rides C and D, which lack lactose group, is totally
unknown. They might be produced by an unknown
degradation mechanism from larger milk oligosac-
charides.
In any event, the report of Kitagawa et al.
indicated that we would be able to pick up even a
very minor oligosaccharide with particular ligand
speciﬁcity, if a proper aﬃnity chromatographic
method is devised by isolating receptor proteins on
the surface of bacteria and viruses. Perhaps, this can
be performed in the near future by collaborating with
the bacteriologists and virologists, who are inves-
tigating the virulent factors by cloning the surface
lectins of bacteria and viruses.
The report of Perret et al.101) can be consid-
ered as a pioneering work for this line of inves-
tigation.
For further development of such study, elucida-
tion of the structures of all human milk oligosaccha-
rides is also indispensable. As described already, 13
diﬀerent core oligosaccharides were found for human
milk oligosaccharides. Whether additional larger
cores exist or not, and the rules in locations of
additional fucoses and sialic acid residues remain to
be elucidated. Accumulation of such results may be
useful for elucidating the structural rules in the
polylactosamine chains, which occur widely in the
sugar chains of glycoproteins, glycolipids and proteo-
glycans.
Human milk contains more than three times of
sialylated oligosaccharides of cow’s milk. It is known
that these sialylated oligosaccharides are absorbed
from digestive tracts of babies, and used for the
biosynthesis of glycoproteins and glycolipids in their
brain.104) It was also found that learning and memory
are improved in piglets by administering sialic
acid.105) Development of this line of studies will
aﬀord another improvement for artiﬁcial nourish-
ment of babies.
I would like to recommend readers of this review
to read another comprehensive review of structures
and functions of human milk oligosaccharides written
recently by Urashima et al.106)
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